CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 602 enrolled
Drug / intervention
Diclofenacdrug
Likely dose
Diclofenac 35 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01510912
NCT01510912Phase 3Completed
CompareCT.gov

A Multicenter, Open-Label, Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip

Iroko Pharmaceuticals, LLC·interventional·Posted Jan 18, 2012·Updated May 9, 2014

In Brief

A Phase 3 clinical trial evaluating Diclofenac for Osteoarthritis. Completed, enrolled 602 participants across 40 sites.

Detailed Summary

The purpose of this study is to evaluate the safety of Diclofenac \[Test\] Capsules for the treatment of osteoarthritis pain of the knee or hip.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 18, 2012
Enrollment StartJan 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.5 years ago

Interventions

Diclofenacdrug

35 mg bid or tid Capsules